Crypto Millionaire: “Pay Attention to May 20th”
Charlie Shrem is like the “Godfather of Cryptocurrencies”. He discovered Bitcoin when it was trading for $5. Ethereum at $109. Binance at just $6. Cardano for 5 CENTS.

Today, he’s sharing the details of a $0.21 CENT crypto with Top 5 Potential… as well as his BIG prediction for May 20th.
Get the details NOW.

PCSA Insider Trading (Processa Pharmaceuticals)

Insider Ownership Percentage: 26.50%
Insider Buying (Last 12 Months): $154,206.00
Insider Selling (Last 12 Months): $52,520.20

Processa Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Processa Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Processa Pharmaceuticals Share Price & Price History

Current Price: $1.58
Price Change: Price Decrease of -0.1 (-5.95%)
As of 05/17/2022 12:38 PM ET

This chart shows the closing price history over time for PCSA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The U.S. Solution to China's Copper Grab
China consumes 54% of the world's copper. Yet China mines only 8% of its copper needs, while plundering Africa, Latin America and South America for copper. The U.S. is left scrambling for new copper sources. But there's a North American copper sweet spot overlooked by China – for now.
Find Out Where This Copper Hotspot Is

Processa Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/6/2022Patrick LinInsiderBuy1,200$3.13$3,756.00431,390View SEC Filing Icon  
1/27/2022Justin W. YorkeDirectorSell1,854$3.30$6,118.20View SEC Filing Icon  
12/14/2021Patrick LinInsiderBuy3,000$4.00$12,000.00View SEC Filing Icon  
12/6/2021Justin W. YorkeDirectorSell4,200$4.71$19,782.00View SEC Filing Icon  
12/3/2021Justin W. YorkeDirectorSell5,500$4.84$26,620.00View SEC Filing Icon  
12/3/2021Patrick LinInsiderBuy3,500$4.80$16,800.00View SEC Filing Icon  
8/26/2021Patrick LinInsiderBuy4,000$6.02$24,080.00422,890View SEC Filing Icon  
6/23/2021David YoungCEOBuy10,000$7.67$76,700.00345,190View SEC Filing Icon  
6/22/2021Robert Michael FloydCOOBuy2,000$7.03$14,060.0028,000View SEC Filing Icon  
6/21/2021James H. StankerCFOBuy1,000$6.81$6,810.0036,510View SEC Filing Icon  
4/13/2021Justin W. YorkeDirectorSell6,500$9.86$64,090.00300,706View SEC Filing Icon  
4/13/2021Justin W. YorkeDirectorSell6,500$9.86$64,090.00300,706View SEC Filing Icon  
4/8/2021James E BesserInsiderSell400,000$10.76$4,304,000.001,064,300View SEC Filing Icon  
4/6/2021James E BesserInsiderSell31,771$10.91$346,621.611,064,300View SEC Filing Icon  
2/22/2021James E BesserMajor ShareholderSell20,929$11.56$241,939.241,120,000View SEC Filing Icon  
2/18/2021James E BesserMajor ShareholderSell5,000$11.35$56,750.001,120,000View SEC Filing Icon  
10/2/2020James E BesserMajor ShareholderBuy30,000$4.04$121,200.00405,000View SEC Filing Icon  
See Full Table
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

SEC Filings (Institutional Ownership Changes) for Processa Pharmaceuticals (NASDAQ:PCSA)

8.34% of Processa Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PCSA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Processa Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/23/2022BlackRock Inc.30,501$0.15M0.0%+12.9%0.194%Search for SEC Filing on Google Icon
2/15/2022Coastal Bridge Advisors LLC32,500$0.16M0.0%+18.2%0.207%Search for SEC Filing on Google Icon
2/10/2022AIGH Capital Management LLC303,703$1.49M0.5%-21.5%1.932%Search for SEC Filing on Google Icon
1/26/2022Verdence Capital Advisors LLC63,227$0.31M0.0%-14.3%0.402%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC64,902$0.56M0.0%+73.5%0.416%Search for SEC Filing on Google Icon
10/29/2021Janney Montgomery Scott LLC46,231$0.40M0.0%-18.5%0.296%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC54,154$0.44M0.0%-42.4%0.348%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC10,106$83K0.0%-23.0%0.065%Search for SEC Filing on Google Icon
8/16/2021State Street Corp16,600$0.14M0.0%N/A0.107%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC37,400$0.31M0.0%+34.4%0.240%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.373,171$3.06M0.0%+136.7%2.397%Search for SEC Filing on Google Icon
8/10/2021Coastal Bridge Advisors LLC27,500$0.23M0.0%+37.5%0.177%Search for SEC Filing on Google Icon
8/9/2021Vectors Research Management LLC4,000$33K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC13,117$0.14M0.0%N/A0.085%Search for SEC Filing on Google Icon
5/19/2021Worth Venture Partners LLC90,968$0.94M0.5%N/A0.586%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC93,999$1.03M0.0%-12.0%0.606%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC13,117$0.14M0.0%N/A0.085%Search for SEC Filing on Google Icon
5/17/2021Coastal Bridge Advisors LLC20,000$0.22M0.0%N/A0.129%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp12,845$0.14M0.0%N/A0.083%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC27,825$0.30M0.0%N/A0.179%Search for SEC Filing on Google Icon
5/12/2021Essex Investment Management Co. LLC72,908$0.80M0.1%-2.7%0.470%Search for SEC Filing on Google Icon
5/4/2021Commonwealth Equity Services LLC10,550$0.12M0.0%N/A0.068%Search for SEC Filing on Google Icon
4/27/2021Janney Montgomery Scott LLC63,331$0.69M0.0%-4.5%0.408%Search for SEC Filing on Google Icon
2/13/2021Essex Investment Management Co. LLC74,928$0.49M0.1%N/A0.709%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Processa Pharmaceuticals logo
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase II clinical trials for the treatment of necrobiosis lipoidica, a chronic disfiguring condition. The company is also developing PCS12852, a novel selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist that is in Phase II clinical trials for the treatment of gastroparesis; and PCS6422, an oral, potent, selective, and irreversible inhibitor that is in Phase I clinical trials for treating metastatic colorectal and breast cancer. It has a license agreement with Akashi Therapeutics, Inc. to develop and commercialize PCS100, an anti-fibrotic and anti-inflammatory drug. The company was incorporated in 2011 and is based in Hanover, Maryland.
Read More on Processa Pharmaceuticals

Today's Range

Now: $1.58
Low: $1.58
High: $1.64

50 Day Range

MA: $2.98
Low: $1.68
High: $3.99

52 Week Range

Now: $1.58
Low: $1.62
High: $8.99

Volume

392 shs

Average Volume

45,373 shs

Market Capitalization

$25.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.1

Who are the company insiders with the largest holdings of Processa Pharmaceuticals?

Processa Pharmaceuticals' top insider investors include:
  1. James E Besser (Major Shareholder)
  2. James E Besser (Insider)
  3. Patrick Lin (Insider)
  4. David Young (CEO)
  5. Justin W Yorke (Director)
  6. James H Stanker (CFO)
  7. Robert Michael Floyd (COO)
Learn More about top insider investors at Processa Pharmaceuticals.
How the Pros Choose Their Stocks
Grab your seat at our free, LIVE, masterclass for traders.

It’s your chance to learn how to pick the right stocks and find the market bottom.

We’ll reveal 3 Tips for dodging volatility and a few under-the-radar stocks we believe have significant potential in the long run.
Click here now to register.